{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"5"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"5"},{"groupId":"OG008","value":"16"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"5"},{"groupId":"OG008","value":"21"}],"units":"Participants"}],"description":"Frequency and severity of adverse events","groups":[{"description":"Part A Dose Level 1 NM21-1490-Q2W 0.15mg","id":"OG000","title":"Part A Dose Level 1 NM21-1490-Q2W 0.15mg"},{"description":"Part A Dose Level 2 NM21-1490-Q2W 1.5mg","id":"OG001","title":"Part A Dose Level 2 NM21-1490-Q2W 1.5mg"},{"description":"Part A Dose Level 3 NM21-1490-Q2W 8mg","id":"OG002","title":"Part A Dose Level 3 NM21-1490-Q2W 8mg"},{"description":"Part A Dose Level 4 NM21-1490-Q2W 24mg","id":"OG003","title":"Part A Dose Level 4 NM21-1490-Q2W 24mg"},{"description":"Part A Dose Level 5 NM21-1490-Q2W 80mg","id":"OG004","title":"Part A Dose Level 5 NM21-1490-Q2W 80mg"},{"description":"Part A Dose Level 6 NM21-1490-Q2W 240mg","id":"OG005","title":"Part A Dose Level 6 NM21-1490-Q2W 240mg"},{"description":"Part A Dose Level 7 NM21-1490-Q2W 800mg","id":"OG006","title":"Part A Dose Level 7 NM21-1490-Q2W 800mg"},{"description":"Part A2 NM32-1480-Q2W 1400mg","id":"OG007","title":"Part A2 NM32-1480-Q2W"},{"description":"Part B NM32-1480-Q2W 800mg","id":"OG008","title":"Part B NM32-1480-Q2W"}],"paramType":"NUMBER","populationDescription":"Participant with any TREA","reportingStatus":"POSTED","timeFrame":"From baseline to up to 12 weeks post last dose, up to 48 weeks.","title":"Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v5.0","type":"PRIMARY","unitOfMeasure":"participants"}